IBDEI1VR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31937,1,3,0)
 ;;=3^Epidermal cyst
 ;;^UTILITY(U,$J,358.3,31937,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,31937,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,31938,0)
 ;;=L20.84^^126^1608^1
 ;;^UTILITY(U,$J,358.3,31938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31938,1,3,0)
 ;;=3^Eczema, intrinsic (allergic)
 ;;^UTILITY(U,$J,358.3,31938,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,31938,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,31939,0)
 ;;=M25.471^^126^1608^7
 ;;^UTILITY(U,$J,358.3,31939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31939,1,3,0)
 ;;=3^Effusion, right ankle
 ;;^UTILITY(U,$J,358.3,31939,1,4,0)
 ;;=4^M25.471
 ;;^UTILITY(U,$J,358.3,31939,2)
 ;;=^5011594
 ;;^UTILITY(U,$J,358.3,31940,0)
 ;;=M25.472^^126^1608^5
 ;;^UTILITY(U,$J,358.3,31940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31940,1,3,0)
 ;;=3^Effusion, left ankle
 ;;^UTILITY(U,$J,358.3,31940,1,4,0)
 ;;=4^M25.472
 ;;^UTILITY(U,$J,358.3,31940,2)
 ;;=^5011595
 ;;^UTILITY(U,$J,358.3,31941,0)
 ;;=M25.474^^126^1608^8
 ;;^UTILITY(U,$J,358.3,31941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31941,1,3,0)
 ;;=3^Effusion, right foot
 ;;^UTILITY(U,$J,358.3,31941,1,4,0)
 ;;=4^M25.474
 ;;^UTILITY(U,$J,358.3,31941,2)
 ;;=^5011597
 ;;^UTILITY(U,$J,358.3,31942,0)
 ;;=M25.475^^126^1608^6
 ;;^UTILITY(U,$J,358.3,31942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31942,1,3,0)
 ;;=3^Effusion, left foot
 ;;^UTILITY(U,$J,358.3,31942,1,4,0)
 ;;=4^M25.475
 ;;^UTILITY(U,$J,358.3,31942,2)
 ;;=^5011598
 ;;^UTILITY(U,$J,358.3,31943,0)
 ;;=I82.401^^126^1608^10
 ;;^UTILITY(U,$J,358.3,31943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31943,1,3,0)
 ;;=3^Embolism/Thrombos Rt Lower Extrem Deep Veins,Acute
 ;;^UTILITY(U,$J,358.3,31943,1,4,0)
 ;;=4^I82.401
 ;;^UTILITY(U,$J,358.3,31943,2)
 ;;=^5007854
 ;;^UTILITY(U,$J,358.3,31944,0)
 ;;=I82.402^^126^1608^9
 ;;^UTILITY(U,$J,358.3,31944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31944,1,3,0)
 ;;=3^Embolism/Thrombos Lft Lower Extrem Deep Veins,Acute
 ;;^UTILITY(U,$J,358.3,31944,1,4,0)
 ;;=4^I82.402
 ;;^UTILITY(U,$J,358.3,31944,2)
 ;;=^5007855
 ;;^UTILITY(U,$J,358.3,31945,0)
 ;;=R60.9^^126^1608^4
 ;;^UTILITY(U,$J,358.3,31945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31945,1,3,0)
 ;;=3^Edema, unspec
 ;;^UTILITY(U,$J,358.3,31945,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,31945,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,31946,0)
 ;;=R60.1^^126^1608^2
 ;;^UTILITY(U,$J,358.3,31946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31946,1,3,0)
 ;;=3^Edema, generalized
 ;;^UTILITY(U,$J,358.3,31946,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,31946,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,31947,0)
 ;;=R60.0^^126^1608^3
 ;;^UTILITY(U,$J,358.3,31947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31947,1,3,0)
 ;;=3^Edema, localized
 ;;^UTILITY(U,$J,358.3,31947,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,31947,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,31948,0)
 ;;=M79.7^^126^1609^160
 ;;^UTILITY(U,$J,358.3,31948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31948,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,31948,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,31948,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,31949,0)
 ;;=M80.061A^^126^1609^385
 ;;^UTILITY(U,$J,358.3,31949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31949,1,3,0)
 ;;=3^Path fx age-rel osteo, rt lwr leg, init
 ;;^UTILITY(U,$J,358.3,31949,1,4,0)
 ;;=4^M80.061A
 ;;^UTILITY(U,$J,358.3,31949,2)
 ;;=^5013459
 ;;^UTILITY(U,$J,358.3,31950,0)
 ;;=M80.062A^^126^1609^383
 ;;^UTILITY(U,$J,358.3,31950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31950,1,3,0)
 ;;=3^Path fx age-rel osteo, lft lwr leg, init
